BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10084779)

  • 1. Interactions between glucocorticoids and the growth hormone-insulin-like growth factor axis.
    Tönshoff B; Mehls O
    Pediatr Transplant; 1997 Nov; 1(2):183-9. PubMed ID: 10084779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of GH.
    Müller EE; Rigamonti AE; Cella SG
    J Endocrinol Invest; 2003; 26(10 Suppl):2-15. PubMed ID: 15497655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss).
    Gabillard JC; Kamangar BB; Montserrat N
    J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of glucocorticoids with the growth hormone-insulin-like growth factor axis and its effects on growth plate chondrocytes and bone cells.
    Mehls O; Himmele R; Hömme M; Kiepe D; Klaus G
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1475-82. PubMed ID: 11837502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic hormones modulate the effect of growth hormone (GH) on insulin-like growth factor-I (IGF-I) mRNA level in primary culture of salmon hepatocytes.
    Pierce AL; Fukada H; Dickhoff WW
    J Endocrinol; 2005 Feb; 184(2):341-9. PubMed ID: 15684342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic renal failure and prednisolone on the growth hormone-insulin-like growth factor axis.
    Kapila P; Jones J; Rees L
    Pediatr Nephrol; 2001 Dec; 16(12):1099-104. PubMed ID: 11793109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis.
    Silva JR; Figueiredo JR; van den Hurk R
    Theriogenology; 2009 May; 71(8):1193-208. PubMed ID: 19193432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins.
    Torre G; Barreca A; Borgonovo G; Minuto M; Ansaldo GL; Varaldo E; Minuto F
    Surgery; 2000 Jan; 127(1):99-103. PubMed ID: 10660765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis.
    Segal-Lieberman G; Rubinfeld H; Glick M; Kronfeld-Schor N; Shimon I
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E982-8. PubMed ID: 16603725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in biological and immunological activity of growth hormone during the neonatal period.
    Pagani S; Chaler EA; Radetti G; Travaglino P; Meazza C; Bozzola E; Sessa N; Belgorosky A; Bozzola M
    Horm Res; 2007; 68(3):145-9. PubMed ID: 17377396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the IGF-IGFBP axis in critical illness.
    Baxter RC
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):421-34. PubMed ID: 11800515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
    Denko CW; Malemud CJ
    Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.